First, a study on serological biomarkers demonstrated that the subgroup of ACPA-negative RA patients achieving SDFR is characterized by higher levels of inflammatory markers (SAA, CRP) and matrix metalloproteinase-3 (MMP-3) at diagnosis [9]. Here, MMP3 is linked to rheumatoid arthritis.